{"id":{"repo_id":"vcu","oai_identifier":"oai:scholarscompass.vcu.edu:etd_retro-1069"},"canonical_url":"https://search.ndltd.org/etd/vcu/oai:scholarscompass.vcu.edu:etd_retro-1069","repository":{"repo_id":"vcu","name":"Virginia Commonwealth University","base_url":"https://scholarscompass.vcu.edu/do/oai/"},"display":{"title":"The Discriminative Stimulus Properties of the Atypical Antipsychotic Ziprasidone in Rats","abstract":"Ziprasidone (ZPD) is an atypical antipsychotic drug (APD) that has been shown to fully substitute in C57BL/6 mice for the discriminative stimulus properties of the atypical APD clozapine (CLZ). In rats, however, it has failed to substitute for either 1.25 mg/kg or 5.0 mg/kg training doses of CLZ. Here the discriminative stimulus properties of ZPD were examined by training 19 adult male Sprague-Dawley rats to discriminate 2.0 mg/kg ZPD from vehicle in a two-lever drug discrimination procedure (ED50 = 0.07 mg/kg). The atypical APD CLZ produced full substitution (ED50 =0.76 mg/kg), as did the atypical APDs zotepine (ED50 = 0.63 mg/kg), olanzapine (ED50 = 0.25 mg/kg), quetiapine (ED50 = 0.93 mg/kg), and risperidone (ED50 = 0.09 mg/kg). The 5-HT2A antagonist ritanserin also fully substituted for ZPD (ED50 = 1.27 mg/kg). Partial substitution (2A/B/C receptors play an important role in the discriminative stimulus properties of ZPD and perhaps the ratio of binding to 5-HT2A/B/C and D2 receptors. While it will be necessary to test additional APDs, these initial findings suggest that ZPD drug discrimination may be a useful model to differentiate atypical from typical APDs.","abstract_html":"Ziprasidone (ZPD) is an atypical antipsychotic drug (APD) that has been shown to fully substitute in C57BL/6 mice for the discriminative stimulus properties of the atypical APD clozapine (CLZ). In rats, however, it has failed to substitute for either 1.25 mg/kg or 5.0 mg/kg training doses of CLZ. Here the discriminative stimulus properties of ZPD were examined by training 19 adult male Sprague-Dawley rats to discriminate 2.0 mg/kg ZPD from vehicle in a two-lever drug discrimination procedure (ED50 = 0.07 mg/kg). The atypical APD CLZ produced full substitution (ED50 =0.76 mg/kg), as did the atypical APDs zotepine (ED50 = 0.63 mg/kg), olanzapine (ED50 = 0.25 mg/kg), quetiapine (ED50 = 0.93 mg/kg), and risperidone (ED50 = 0.09 mg/kg). The 5-HT2A antagonist ritanserin also fully substituted for ZPD (ED50 = 1.27 mg/kg). Partial substitution (2A/B/C receptors play an important role in the discriminative stimulus properties of ZPD and perhaps the ratio of binding to 5-HT2A/B/C and D2 receptors. While it will be necessary to test additional APDs, these initial findings suggest that ZPD drug discrimination may be a useful model to differentiate atypical from typical APDs.","abstract_has_math":false,"creators":["Wood, Erin"],"institution":null,"degree_name":"Master of Science","degree_level":"Thesis","degree_discipline":"Psychology","degree_department":null,"school":null,"contributors":["Dr. Joseph H. Porter"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T09:15:52Z","subjects":["clozapine","drug discrimination","schizophrenia","ziprasidone","Psychology","Social and Behavioral Sciences"],"languages":[],"rights":["© The Author"],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://scholarscompass.vcu.edu/etd_retro/70","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://scholarscompass.vcu.edu/etd_retro/70","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://scholarscompass.vcu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ascholarscompass.vcu.edu%3Aetd_retro-1069","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Joseph H. Porter"]},{"key":"dc:creator","label":"Author","values":["Wood, Erin"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-12-09T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2007-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Psychology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["clozapine","drug discrimination","schizophrenia","ziprasidone","Psychology","Social and Behavioral Sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["© The Author"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://scholarscompass.vcu.edu/etd_retro/70"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Ziprasidone (ZPD) is an atypical antipsychotic drug (APD) that has been shown to fully substitute in C57BL/6 mice for the discriminative stimulus properties of the atypical APD clozapine (CLZ). In rats, however, it has failed to substitute for either 1.25 mg/kg or 5.0 mg/kg training doses of CLZ. Here the discriminative stimulus properties of ZPD were examined by training 19 adult male Sprague-Dawley rats to discriminate 2.0 mg/kg ZPD from vehicle in a two-lever drug discrimination procedure (ED50 = 0.07 mg/kg). The atypical APD CLZ produced full substitution (ED50 =0.76 mg/kg), as did the atypical APDs zotepine (ED50 = 0.63 mg/kg), olanzapine (ED50 = 0.25 mg/kg), quetiapine (ED50 = 0.93 mg/kg), and risperidone (ED50 = 0.09 mg/kg). The 5-HT2A antagonist ritanserin also fully substituted for ZPD (ED50 = 1.27 mg/kg). Partial substitution (2A/B/C receptors play an important role in the discriminative stimulus properties of ZPD and perhaps the ratio of binding to 5-HT2A/B/C and D2 receptors. While it will be necessary to test additional APDs, these initial findings suggest that ZPD drug discrimination may be a useful model to differentiate atypical from typical APDs."]},{"key":"dc:description.note","label":"Dc Description Note","values":["Part of Retrospective ETD Collection, restricted to VCU only."]},{"key":"dc:title","label":"Title","values":["The Discriminative Stimulus Properties of the Atypical Antipsychotic Ziprasidone in Rats"]}]}],"canonical_facts":{"dc:contributor":["Dr. Joseph H. Porter"],"dc:creator":["Wood, Erin"],"dc:date.available":["2024-12-09T08:00:00Z"],"dc:date.created":["2007-01-01T08:00:00Z"],"dc:description.abstract":["Ziprasidone (ZPD) is an atypical antipsychotic drug (APD) that has been shown to fully substitute in C57BL/6 mice for the discriminative stimulus properties of the atypical APD clozapine (CLZ). In rats, however, it has failed to substitute for either 1.25 mg/kg or 5.0 mg/kg training doses of CLZ. Here the discriminative stimulus properties of ZPD were examined by training 19 adult male Sprague-Dawley rats to discriminate 2.0 mg/kg ZPD from vehicle in a two-lever drug discrimination procedure (ED50 = 0.07 mg/kg). The atypical APD CLZ produced full substitution (ED50 =0.76 mg/kg), as did the atypical APDs zotepine (ED50 = 0.63 mg/kg), olanzapine (ED50 = 0.25 mg/kg), quetiapine (ED50 = 0.93 mg/kg), and risperidone (ED50 = 0.09 mg/kg). The 5-HT2A antagonist ritanserin also fully substituted for ZPD (ED50 = 1.27 mg/kg). Partial substitution (2A/B/C receptors play an important role in the discriminative stimulus properties of ZPD and perhaps the ratio of binding to 5-HT2A/B/C and D2 receptors. While it will be necessary to test additional APDs, these initial findings suggest that ZPD drug discrimination may be a useful model to differentiate atypical from typical APDs."],"dc:description.note":["Part of Retrospective ETD Collection, restricted to VCU only."],"dc:identifier":["https://scholarscompass.vcu.edu/etd_retro/70"],"dc:rights":["© The Author"],"dc:subject":["clozapine","drug discrimination","schizophrenia","ziprasidone","Psychology","Social and Behavioral Sciences"],"dc:title":["The Discriminative Stimulus Properties of the Atypical Antipsychotic Ziprasidone in Rats"],"thesis:degree_discipline":["Psychology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science"]},"updated_at":"2026-11-19T09:15:52Z"}